Evidence map›Paper›PMID 16474115›Full record

ArticleJournal of virology2006

Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of Varicella-Zoster virus.

Randall J Cohrs, Donald H Gilden, Yasuyuki Gomi, Koichi Yamanishi, Jeffrey I Cohen

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Prevention of shingles: safety and efficacy of live zoster vaccine.Therapeutics and clinical risk management · 2007
    Article
  18. Article
  19. Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Randall J CohrsDepartment of Neurology, University of Colorado Health Sciences Center, Denver, 80262, USA. randall.cohrs@uchsc.edu
Donald H Gilden
Yasuyuki Gomi
Koichi Yamanishi
Jeffrey I Cohen
National Institute of Biomedical Innovation, Health and Nutrition · JPNational Institutes of Health Clinical Center · USOsaka University · JPUniversity of Colorado Health · US

Funding

Varicella Zoster Virus Latency in Human GangliaP01NS032623 · NINDS · UNIVERSITY OF COLORADO DENVER · PI MAHLAINGAM, RAVI · 1993 to 2008
$12.3M
NEUROBIOLOGY OF VARICELLA-ZOSTER VIRUSR01AG006127 · NIA · UNIVERSITY OF COLORADO DENVER · PI GILDEN, DONALD · 1987 to 2014
$4.2M
NEUROBIOLOGY OF VARICELLA ZOSTER VIRUSR37AG006127 · NIA · UNIVERSITY OF COLORADO DENVER · PI GILDEN, DONALD H · 1995 to 2004
$2.3M
MOLECULAR BIOLOGY OF VARICELLA-ZOSTER VIRUS INFECTIONSZ01AI000430 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI COHEN, JEFFREY · 1985 to 2008
$680k
Intramural NIH HHSNIA NIH HHS AG06127NIA NIH HHS R01 AG006127NIA NIH HHS R37 AG006127NINDS NIH HHS NS 32623NINDS NIH HHS P01 NS032623
6 · The paper itself

Abstract

The attenuated Oka vaccine (V-Oka) strain of varicella-zoster virus (VZV) effectively reduces disease produced by primary infection and virus reactivation. V-Oka was developed by propagation of the Oka parental (P-Oka) strain of VZV in guinea pig and human embryo fibroblasts. Complete DNA sequencing of both viruses has revealed 63 sites that differ between P-Oka and V-Oka, 37 of which are located within 21 unique open reading frames (ORFs). Of the ORFs that differ, ORF 62 contains the greatest number (10) of mutated sites. ORF 62 encodes IE 62, the major immediate-early transactivator of virus genes, and is essential for lytic virus replication. To determine whether a disproportionate number of mutations in ORF 62 might account for virus attenuation, we compared the global pattern of V-Oka gene expression to that of P-Oka. Transcription of ORFs 62, 65, 66, and 67 was suppressed, whereas ORF 41 was elevated in V-Oka-infected cells compared to P-Oka-infected cells (P < 0.01; z test). Suppression of ORF 62, 65, and 66 transcription was confirmed by quantitative dot blot and Western blot analyses. Transient-transfection assays to determine whether mutations within V-Oka-derived IE 62 affected its ability to transactivate VZV gene promoters revealed similar IE 62 transactivation of VZV gene 20, 21, 28, 29, 65, and 66 promoters in both P-Oka and V-Oka. Together, our results indicate that mutations in V-Oka IE 62 alone are unlikely to account for vaccine virus attenuation.

Indexed as

Gene Expression Regulation, ViralOligonucleotide Array Sequence AnalysisBlotting, WesternCell LineChickenpox VaccineFibroblastsGenes, ViralHerpesvirus 3, HumanHumansImmediate-Early ProteinsNucleic Acid HybridizationOpen Reading FramesRNA, MessengerRNA, ViralTrans-ActivatorsTranscription, GeneticChickenpox VaccineIE62 protein, Human herpesvirus 3Immediate-Early ProteinsRNA, MessengerRNA, ViralTrans-ActivatorsViral Envelope ProteinsViral Proteins

Identifiers

PMID16474115
PMCPMC1395396
OpenAlexW1991700871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.